Boundary Capital was set up in 2009 initially from a network of business angels to become a venture capital company focusing on early stage technology investments that positively impact and improve lives.
The Company’s headquarters are in London and it covers investments throughout the UK.
As well as funding, we can also provide commercial assistance, including business development. We have a network of over 300 investing directors with specific expertise who can help open doors with customers and partners, as well as advise and help shape and develop your business.
OUR UNIQUE VENTURER MODEL
Our ‘Venturer’ model means that we find executives with appropriate sector expertise, who are able to provide support and connections to the management team. The Venturer also invests in the business, thus aligning all stakeholders. We engage with Venturers as soon possible in the process so help us and the management of the business to assess the fit.
OUR VALUES
Boundary Capital focuses on technologies that have a positive impact on the way we live our lives. These include:
Life science technologies that are focused around long-term health and particularly around increasing and sustaining quality of life for all
Engineering innovations that assist humans to build and curate a more sustainable environment, lowering pollution and carbon footprints
Software and data science innovations that empower and democratise skills and knowledge for the benefit of all
OUR TEAM

Dan Somers
Managing Partner
Formerly a strategy consultant with LEK Consulting. He holds an MA from Cambridge University in Natural Sciences and a Diploma in Business Studies.

Dr Richard Leaver
Partner
Formerly in senior roles with Cambridge based consultancy Sagentia Group, following 11 years with BAE Systems in R&D. He holds a Ph.D. in Artificial Intelligence from Durham University as well as MBA, C.Eng., MIET and MIEEE.

Dr David Gee
Partner

Dr Adrian Parton MBE
Partner
He has been in industry for the last 25 years and has successfully grown businesses from concept to production and subsequently into multi-national businesses in the areas of water diagnostics (Genera Technologies Ltd – sold in 2000 to Idexx Labs Inc for $17m), food diagnostics (Matrix MicroScience Ltd – sold to Life Technologies Inc for $20m) and “e-banking” using software and hardware (Cronto – sold to Vasco Data Security in 2013 for €17m). Adrian is currently a Director of; Objective Imaging Ltd (Hardware Software Automation business), DenovoPartners Ltd (provides strategic support for growing businesses), Snapa Ltd (novel packing solutions), and Chairman/Owner of Ivy House Country House Hotel.